Glucotrack’s CEO Paul V. Goode told Medical Device Network: "In a survey of 757 patients, we found significant interest in an implantable continuous glucose monitor. The most appealing features ...

Goode, expressed enthusiasm about the results, indicating that this technology brings continuous glucose monitoring ... with diabetes. Glucotrack’s CBGM is a long-term, implantable system ...

As the diabetes management industry continues to evolve, Glucotrack stands to potentially redefine continuous glucose monitoring. The CBGM is not just another iteration of existing technology ...

Glucotrack (GCTK) announced that Ted Williams ... a technology innovator focused on development of an implantable CGM. Published first on TheFly – the ultimate source for real-time, market ...

The CBGM is designed for a less intrusive approach to continuous glucose monitoring ... term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack ...

Leading diabetes researcher and clinician joins Glucotrack as Company advances ... marking a significant milestone in continuous glucose monitoring. This s 1-for-20 reverse stock split to become ...

He served as Vice President, Regulatory Affairs/Quality Assurance for Glysens Inc, a technology innovator focused on development of an implantable CGM ... Officer of Glucotrack, said:“Mr ...

Although this initial study was not intended to measure sensor accuracy, Glucotrack noted that the system performed as expected, delivering results in line with preclinical animal studies. This ...

RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack ... marking a significant milestone in continuous glucose monitoring. This study represents the first real-time, continuous blood ...

RUTHERFORD, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on ...